{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:48:25Z","timestamp":1779245305692,"version":"3.51.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09484-9","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:45:46Z","timestamp":1768373146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A microphysiological model of human MASLD reveals paradoxical response to resmetirom"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-399X","authenticated-orcid":false,"given":"Dominick J.","family":"Hellen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Ungerleider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-1957","authenticated-orcid":false,"given":"Erin","family":"Tevonian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Sphabmixay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyatanu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-0187","authenticated-orcid":false,"given":"Nikolaos","family":"Meimetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Presutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4185-7742","authenticated-orcid":false,"given":"Ryan C.","family":"Ogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-5084","authenticated-orcid":false,"given":"Caroline A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-1815","authenticated-orcid":false,"given":"Sixian","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Demozay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-5548","authenticated-orcid":false,"given":"Linda G.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"9484_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher, G., Corey, K. E., Byrne, C. D. & Roden, M. The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol. 18, 599\u2013612 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9484_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi0759","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang, S. & Friedman, S. L. Found in translation\u2014Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Sci. Transl. Med. 15, eadi0759 (2023).","journal-title":"Sci. Transl. Med."},{"key":"9484_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden, M. & Shulman, G. I. The integrative biology of type 2 diabetes. Nature 576, 51\u201360 (2019).","journal-title":"Nature"},{"key":"9484_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"9484_CR5","doi-asserted-by":"publisher","unstructured":"Green, C. J. et al. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Horm. Mol. Biol. Clin. Investig. https:\/\/doi.org\/10.1515\/hmbci-2018-0038 (2018).","DOI":"10.1515\/hmbci-2018-0038"},{"key":"9484_CR6","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1177\/15353702211009228","volume":"246","author":"M Saydmohammed","year":"2021","unstructured":"Saydmohammed, M. et al. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Exp. Biol. Med. 246, 2420\u20132441 (2021).","journal-title":"Exp. Biol. Med."},{"key":"9484_CR7","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/ijms22084156","volume":"22","author":"Y Sakurai","year":"2021","unstructured":"Sakurai, Y., Kubota, N., Yamauchi, T. & Kadowaki, T. Role of insulin resistance in MAFLD. Int. J. Mol. Sci. 22, 4156 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"9484_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1152\/physiol.00048.2018","volume":"34","author":"SM Najjar","year":"2019","unstructured":"Najjar, S. M. & Perdomo, G. Hepatic insulin clearance: mechanism and physiology. Physiology 34, 198\u2013215 (2019).","journal-title":"Physiology"},{"key":"9484_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2337\/dc20-1644","volume":"44","author":"KW Ter Horst","year":"2021","unstructured":"Ter Horst, K. W. et al. Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease. Diabetes Care 44, 489\u2013498 (2021).","journal-title":"Diabetes Care"},{"key":"9484_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep25187","volume":"6","author":"CC Bell","year":"2016","unstructured":"Bell, C. C. et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci. Rep. 6, 25187 (2016).","journal-title":"Sci. Rep."},{"key":"9484_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303785","volume":"13","author":"A Aizenshtadt","year":"2024","unstructured":"Aizenshtadt, A. et al. Pump-Less, recirculating organ-on-chip (rOoC) platform to model the metabolic crosstalk between islets and liver. Adv. Healthc. Mater. 13, 2303785 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"9484_CR12","doi-asserted-by":"crossref","unstructured":"Rigual, M. d. M. et al. Macrophages harness hepatocyte glutamate to boost liver regeneration. Nature 641, 1005\u20131016 (2025).","DOI":"10.1038\/s41586-025-08778-6"},{"key":"9484_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302217","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang, J., Wu, X., Zhao, J., Ren, H. & Zhao, Y. Developing liver microphysiological systems for biomedical applications. Adv. Healthc. Mater. 13, 2302217 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"9484_CR14","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1039\/D2LC00307D","volume":"22","author":"T Messelmani","year":"2022","unstructured":"Messelmani, T. et al. Liver organ-on-chip models for toxicity studies and risk assessment. Lab Chip 22, 2423\u20132450 (2022).","journal-title":"Lab Chip"},{"key":"9484_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep4.1450","volume":"4","author":"T Kostrzewski","year":"2020","unstructured":"Kostrzewski, T. et al. A microphysiological system for studying nonalcoholic steatohepatitis. Hepatol. Commun. 4, 77\u201391 (2020).","journal-title":"Hepatol. Commun."},{"key":"9484_CR16","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven, G. M. Role of insulin resistance in human disease. Diabetes 37, 1595\u20131607 (1988).","journal-title":"Diabetes"},{"key":"9484_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1124\/dmd.115.063495","volume":"43","author":"U Sarkar","year":"2015","unstructured":"Sarkar, U. et al. Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab. Dispos. 43, 1091\u20131099 (2015).","journal-title":"Drug Metab. Dispos."},{"key":"9484_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1124\/jpet.116.237495","volume":"360","author":"N Tsamandouras","year":"2017","unstructured":"Tsamandouras, N. et al. Quantitative assessment of population variability in hepatic drug metabolism using a perfused three-dimensional human liver microphysiological system. J. Pharmacol. Exp. Ther. 360, 95\u2013105 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9484_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s42255-020-0214-9","volume":"2","author":"M Vacca","year":"2020","unstructured":"Vacca, M. et al. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nat. Metab. 2, 514\u2013531 (2020).","journal-title":"Nat. Metab."},{"key":"9484_CR20","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1124\/dmd.116.071456","volume":"44","author":"TJ Long","year":"2016","unstructured":"Long, T. J. et al. Modeling therapeutic antibody-small molecule drug-drug interactions using a three-dimensional perfusable human liver coculture platform. Drug Metab. Dispos. 44, 1940\u20131948 (2016).","journal-title":"Drug Metab. Dispos."},{"key":"9484_CR21","doi-asserted-by":"crossref","unstructured":"Clark, A. et al. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties. Lab Chip. 17, 156\u2013168 (2017).","DOI":"10.1039\/C6LC01171C"},{"key":"9484_CR22","doi-asserted-by":"crossref","unstructured":"Vaupel, P. & Multhoff, G. Blood supply and oxygenation status of the liver: from physiology to malignancy. In Oxygen Transport to Tissue XLIII. 263\u2013267 (Springer International Publishing, Cham, 2022).","DOI":"10.1007\/978-3-031-14190-4_43"},{"key":"9484_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1039\/B913221J","volume":"10","author":"K Domansky","year":"2010","unstructured":"Domansky, K. et al. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10, 51\u201358 (2010).","journal-title":"Lab Chip"},{"key":"9484_CR24","doi-asserted-by":"publisher","unstructured":"Rubiano, A. et al. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism and accumulation. Clin. Transl. Sci. https:\/\/doi.org\/10.1111\/cts.12969 (2020).","DOI":"10.1111\/cts.12969"},{"key":"9484_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"9484_CR26","first-page":"4491","volume":"85","author":"SH Song","year":"2000","unstructured":"Song, S. H. et al. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J. Clin. Endocrinol. Metab. 85, 4491\u20134499 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9484_CR27","doi-asserted-by":"publisher","first-page":"E695","DOI":"10.1152\/ajpendo.00516.2000","volume":"282","author":"N Porksen","year":"2002","unstructured":"Porksen, N. et al. Human insulin release processes measured by intraportal sampling. Am. J. Physiol. Endocrinol. Metab. 282, E695\u2013E702 (2002).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"9484_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/msb.2008.78","volume":"5","author":"VV Kiselyov","year":"2009","unstructured":"Kiselyov, V. V., Versteyhe, S., Gauguin, L. & De Meyts, P. Harmonic oscillator model of the insulin and IGF1 receptors\u2019 allosteric binding and activation. Mol. Syst. Biol. 5, 243 (2009).","journal-title":"Mol. Syst. Biol."},{"key":"9484_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10439-005-9065-5","volume":"34","author":"SS Hori","year":"2006","unstructured":"Hori, S. S., Kurland, I. J. & DiStefano, J. J. 3rd Role of endosomal trafficking dynamics on the regulation of hepatic insulin receptor activity: models for Fao cells. Ann. Biomed. Eng. 34, 879\u2013892 (2006).","journal-title":"Ann. Biomed. Eng."},{"key":"9484_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","volume":"6","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A. & Accili, D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metabolism 6, 208\u2013216 (2007).","journal-title":"Cell Metabolism"},{"key":"9484_CR31","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1074\/jbc.M111.305789","volume":"287","author":"T Li","year":"2012","unstructured":"Li, T. et al. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J. Biol. Chem. 287, 1861\u20131873 (2012).","journal-title":"J. Biol. Chem."},{"key":"9484_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411\u2013428 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9484_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/jn\/135.4.681","volume":"135","author":"B Mittendorfer","year":"2005","unstructured":"Mittendorfer, B. Sexual dimorphism in human lipid metabolism. J. Nutr. 135, 681\u2013686 (2005).","journal-title":"J. Nutr."},{"key":"9484_CR34","doi-asserted-by":"publisher","first-page":"10006","DOI":"10.70322\/fibrosis.2024.10006","volume":"2","author":"M Jamalinia","year":"2024","unstructured":"Jamalinia, M., Lonardo, A. & Weiskirchen, R. Sex and gender differences in liver fibrosis: pathomechanisms and clinical outcomes. Fibrosis 2, 10006 (2024).","journal-title":"Fibrosis"},{"key":"9484_CR35","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","volume":"185","author":"M Kimura","year":"2022","unstructured":"Kimura, M. et al. En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH. Cell 185, 4216\u20134232. e16 (2022).","journal-title":"Cell"},{"key":"9484_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04470-8","volume":"9","author":"S You","year":"2018","unstructured":"You, S. et al. Intravital imaging by simultaneous label-free autofluorescence-multiharmonic microscopy. Nat. Commun. 9, 2125 (2018).","journal-title":"Nat. Commun."},{"key":"9484_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp2438","volume":"10","author":"K Liu","year":"2024","unstructured":"Liu, K. et al. Deep and dynamic metabolic and structural imaging in living tissues. Sci. Adv. 10, eadp2438 (2024).","journal-title":"Sci. Adv."},{"key":"9484_CR38","first-page":"1","volume":"16","author":"X St\u00e9phenne","year":"2010","unstructured":"St\u00e9phenne, X., Najimi, M. & Sokal, E. M. Hepatocyte cryopreservation: is it time to change the strategy? World J. Gastroenterol. 16, 1 (2010).","journal-title":"World J. Gastroenterol."},{"key":"9484_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/2211068214566939","volume":"20","author":"SR Khetani","year":"2015","unstructured":"Khetani, S. R. et al. Microengineered liver tissues for drug testing. J. Lab. Autom. 20, 216\u2013250 (2015).","journal-title":"J. Lab. Autom."},{"key":"9484_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-S18-S1","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 1\u201314 (2013).","journal-title":"BMC Bioinform."},{"key":"9484_CR41","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062\u20136067 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9484_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"9484_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"9484_CR44","doi-asserted-by":"publisher","unstructured":"Grissa, D., Junge, A., Oprea, T. I. & Jensen, L. J. Diseases 2.0: a weekly updated database of disease\u2013gene associations from text mining and data integration. Database. https:\/\/doi.org\/10.1093\/database\/baac019 (2022).","DOI":"10.1093\/database\/baac019"},{"key":"9484_CR45","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2019","unstructured":"Pi\u00f1ero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855 (2019).","journal-title":"Nucleic Acids Res."},{"key":"9484_CR46","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan, A. B. et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 47, W212\u2013W224 (2019).","journal-title":"Nucleic Acids Res."},{"key":"9484_CR47","doi-asserted-by":"publisher","unstructured":"Cadavid, J. L., Meimetis, N., Griffith, L. G. & Lauffenburger, D. A. Systems biology framework for rational design of operational conditions for <em>in vitro \/ in vivo<\/em> translation of microphysiological systems. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.01.17.633624 (2025).","DOI":"10.1101\/2025.01.17.633624"},{"key":"9484_CR48","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s42003-021-02616-x","volume":"4","author":"T Kostrzewski","year":"2021","unstructured":"Kostrzewski, T. et al. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Commun. Biol. 4, 1080 (2021).","journal-title":"Commun. Biol."},{"key":"9484_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48746-5","volume":"9","author":"SA Hoang","year":"2019","unstructured":"Hoang, S. A. et al. Gene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease. Sci. Rep. 9, 12541 (2019).","journal-title":"Sci. Rep."},{"key":"9484_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90954","volume":"1","author":"RE Feaver","year":"2016","unstructured":"Feaver, R. E. et al. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 1, e90954 (2016).","journal-title":"JCI Insight"},{"key":"9484_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-8-48","volume":"8","author":"B Cariou","year":"2011","unstructured":"Cariou, B. et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr. Metab. 8, 1\u20136 (2011).","journal-title":"Nutr. Metab."},{"key":"9484_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M. & Trauner, M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology 65, 350\u2013362 (2017).","journal-title":"Hepatology"},{"key":"9484_CR53","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2337\/db23-0802","volume":"73","author":"C Schott","year":"2024","unstructured":"Schott, C. et al. GAS6 and AXL promote insulin resistance by rewiring insulin signaling and increasing insulin receptor trafficking to endosomes. Diabetes 73, 1648\u20131661 (2024).","journal-title":"Diabetes"},{"key":"9484_CR54","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/nu14214505","volume":"14","author":"T Tian","year":"2022","unstructured":"Tian, T. et al. Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among United States adults, results from NHANES 2017\u20132018. Nutrients 14, 4505 (2022).","journal-title":"Nutrients"},{"key":"9484_CR55","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/nu16142220","volume":"16","author":"M Beygi","year":"2024","unstructured":"Beygi, M., Ahi, S., Zolghadri, S. & Stanek, A. Management of metabolic-associated fatty liver disease\/metabolic dysfunction-associated steatotic liver disease: from medication therapy to nutritional interventions. Nutrients 16, 2220 (2024).","journal-title":"Nutrients"},{"key":"9484_CR56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/HEP.0000000000000551","volume":"81","author":"L Marino","year":"2025","unstructured":"Marino, L., Kim, A., Ni, B. & Celi, F. S. Thyroid hormone action and liver disease, a complex interplay. Hepatology 81, 651\u2013669 (2025).","journal-title":"Hepatology"},{"key":"9484_CR57","doi-asserted-by":"crossref","unstructured":"Li, J., Ayada, I. & Pan, Q. Resmetirom directly inhibits lipid accumulation in human liver-derived organoids. J. Hepatol. 83, e86\u2013e87 (2025).","DOI":"10.1016\/j.jhep.2025.03.022"},{"key":"9484_CR58","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1111\/bph.15427","volume":"178","author":"A Kannt","year":"2021","unstructured":"Kannt, A. et al. Activation of thyroid hormone receptor-\u03b2 improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis. Br. J. Pharmacol. 178, 2412\u20132423 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"9484_CR59","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/ijms24065843","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang, X., Wang, L., Geng, L., Tanaka, N. & Ye, B. Resmetirom ameliorates NASH-model mice by suppressing STAT3 and NF-\u03baB signaling pathways in an RGS5-dependent manner. Int. J. Mol. Sci. 24, 5843 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"9484_CR60","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/dom.16117","volume":"27","author":"SA Polyzos","year":"2025","unstructured":"Polyzos, S. A. & Targher, G. Hepatic thyroid hormone receptor-\u03b2 signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis. Diabetes Obes. Metab. 27, 1635\u20131647 (2025).","journal-title":"Diabetes Obes. Metab."},{"key":"9484_CR61","doi-asserted-by":"publisher","first-page":"1452696","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-P\u00e9rez","year":"2020","unstructured":"Rius-P\u00e9rez, S., Torres-Cuevas, I., Mill\u00e1n, I., Ortega, \u00c1L. & P\u00e9rez, S. PGC-1\u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxid. Med. Cell. Longev. 2020, 1452696 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"9484_CR62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10863-017-9718-8","volume":"49","author":"X Zou","year":"2017","unstructured":"Zou, X. et al. Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox signaling? J. Bioenerg. Biomembr. 49, 325\u2013333 (2017).","journal-title":"J. Bioenerg. Biomembr."},{"key":"9484_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1172\/JCI112558","volume":"78","author":"JF Caro","year":"1986","unstructured":"Caro, J. F. et al. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J. Clin. Invest. 78, 249\u2013258 (1986).","journal-title":"J. Clin. Invest."},{"key":"9484_CR64","doi-asserted-by":"publisher","unstructured":"Koh, H. E., Cao, C. & Mittendorfer, B. Insulin clearance in obesity and type 2 Diabetes. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23020596 (2022).","DOI":"10.3390\/ijms23020596"},{"key":"9484_CR65","doi-asserted-by":"publisher","first-page":"359","DOI":"10.14218\/JCTH.2020.00015","volume":"8","author":"M Duriez","year":"2020","unstructured":"Duriez, M. et al. A 3D human liver model of nonalcoholic steatohepatitis. J. Clin. Transl. Hepatol. 8, 359\u2013370 (2020).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"9484_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32722-6","volume":"8","author":"M Kozyra","year":"2018","unstructured":"Kozyra, M. et al. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci. Rep. 8, 14297 (2018).","journal-title":"Sci. Rep."},{"key":"9484_CR67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1073\/pnas.1809406115","volume":"116","author":"I Cordero-Herrera","year":"2019","unstructured":"Cordero-Herrera, I. et al. AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis. Proc. Natl. Acad. Sci. USA 116, 217\u2013226 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9484_CR68","doi-asserted-by":"publisher","first-page":"152662","DOI":"10.1016\/j.tox.2020.152662","volume":"449","author":"MD Davidson","year":"2021","unstructured":"Davidson, M. D., Pickrell, J. & Khetani, S. R. Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures. Toxicology 449, 152662 (2021).","journal-title":"Toxicology"},{"key":"9484_CR69","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1124\/dmd.116.074005","volume":"45","author":"U Sarkar","year":"2017","unstructured":"Sarkar, U. et al. Integrated assessment of diclofenac biotransformation, pharmacokinetics, and omics-based toxicity in a three-dimensional human liver-immunocompetent coculture system. Drug Metab. Dispos. 45, 855\u2013866 (2017).","journal-title":"Drug Metab. Dispos."},{"key":"9484_CR70","doi-asserted-by":"publisher","unstructured":"Jang, K. J. et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax5516 (2019).","DOI":"10.1126\/scitranslmed.aax5516"},{"key":"9484_CR71","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1039\/D2LC00940D","volume":"23","author":"AE Otumala","year":"2023","unstructured":"Otumala, A. E. et al. Opportunities and considerations for studying liver disease with microphysiological systems on a chip. Lab Chip 23, 2877\u20132898 (2023).","journal-title":"Lab Chip"},{"key":"9484_CR72","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","volume":"6","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease. Commun. Biol. 6, 310 (2023).","journal-title":"Commun. Biol."},{"key":"9484_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01951-7","volume":"11","author":"S Str\u00f6bel","year":"2021","unstructured":"Str\u00f6bel, S. et al. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Sci Rep. 11, 22765 (2021). Nov 23.","journal-title":"Sci Rep."},{"key":"9484_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407572","volume":"12","author":"S Youhanna","year":"2025","unstructured":"Youhanna, S. et al. Chemogenomic screening in a patient-derived 3D fatty liver disease model reveals the CHRM1-TRPM8 axis as a novel module for targeted intervention. Adv. Sci. 12, 2407572 (2025).","journal-title":"Adv. Sci."},{"key":"9484_CR75","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1194\/jlr.P056002","volume":"56","author":"DL Gorden","year":"2015","unstructured":"Gorden, D. L. et al. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J. Lipid Res. 56, 722\u2013736 (2015).","journal-title":"J. Lipid Res."},{"key":"9484_CR76","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson, S. et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J. Hepatol. 62, 1148\u20131155 (2015).","journal-title":"J. Hepatol."},{"key":"9484_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403516","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Dissecting acute drug-induced hepatotoxicity and therapeutic responses of steatotic liver disease using primary mouse liver and blood cells in a liver-on-a-chip model. Adv. Sci. 11, 2403516 (2024).","journal-title":"Adv. Sci."},{"key":"9484_CR78","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1021\/acs.chemrestox.6b00150","volume":"29","author":"VM Lauschke","year":"2016","unstructured":"Lauschke, V. M., Hendriks, D. F., Bell, C. C., Andersson, T. B. & Ingelman-Sundberg, M. Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates. Chem. Res. Toxicol. 29, 1936\u20131955 (2016).","journal-title":"Chem. Res. Toxicol."},{"key":"9484_CR79","doi-asserted-by":"publisher","first-page":"108064","DOI":"10.1016\/j.isci.2023.108064","volume":"26","author":"N Lopez-Alcantara","year":"2023","unstructured":"Lopez-Alcantara, N., Oelkrug, R., Sentis, S. C., Kirchner, H. & Mittag, J. Lack of thyroid hormone receptor beta is not detrimental for non-alcoholic steatohepatitis progression. Iscience 26, 108064 (2023).","journal-title":"Iscience"},{"key":"9484_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1423936","volume":"12","author":"M Xia","year":"2024","unstructured":"Xia, M. et al. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy. Front. Cell Dev. Biol. 12, 1423936 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"9484_CR81","doi-asserted-by":"crossref","unstructured":"Ezhilarasan, D. Thyromimetics and MASLD: unveiling the novel molecules beyond resmetirom. J. Gastroenterol. Hepatol. 40, 367\u2013378 (2025).","DOI":"10.1111\/jgh.16874"},{"key":"9484_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mam.2015.01.003","volume":"42","author":"LS Satin","year":"2015","unstructured":"Satin, L. S., Butler, P. C., Ha, J. & Sherman, A. S. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol. Aspects Med. 42, 61\u201377 (2015).","journal-title":"Mol. Aspects Med."},{"key":"9484_CR83","doi-asserted-by":"publisher","unstructured":"Laurenti, M. C. et al. Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136136 (2020).","DOI":"10.1172\/jci.insight.136136"},{"key":"9484_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14815-w","volume":"7","author":"S Bauer","year":"2017","unstructured":"Bauer, S. et al. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Sci Rep. 7, 14620 (2017).","journal-title":"Sci Rep."},{"key":"9484_CR85","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi, S. E. et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38, 140\u2013149 (2015).","journal-title":"Diabetes Care"},{"key":"9484_CR86","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","volume":"47","author":"L Hodson","year":"2008","unstructured":"Hodson, L., Skeaff, C. M. & Fielding, B. A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47, 348\u2013380 (2008).","journal-title":"Prog. Lipid Res."},{"key":"9484_CR87","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/BF00400814","volume":"36","author":"L Groop","year":"1993","unstructured":"Groop, L., Widen, E. & Ferrannini, E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36, 1326\u20131331 (1993).","journal-title":"Diabetologia"},{"key":"9484_CR88","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res. 29, e45\u2013e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"9484_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"9484_CR90","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"9484_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Parmigiani, G. & Johnson, W. E. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom. Bioinform. 2, lqaa078 (2020).","journal-title":"NAR Genom. Bioinform."},{"key":"9484_CR92","first-page":"245","volume":"129","author":"B Weigelin","year":"2016","unstructured":"Weigelin, B., Bakker, G.-J. & Friedl, P. Third harmonic generation microscopy of cells and tissue organization. J. Cell Sci. 129, 245\u2013255 (2016).","journal-title":"J. Cell Sci."},{"key":"9484_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-bioeng-071516-044730","volume":"25","author":"I Georgakoudi","year":"2023","unstructured":"Georgakoudi, I. & Quinn, K. P. Label-free optical metabolic imaging in cells and tissues. Ann. Rev. Biomed. Eng. 25, 413\u2013443 (2023).","journal-title":"Ann. Rev. Biomed. Eng."},{"key":"9484_CR94","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.21769\/BioProtoc.4776","volume":"13","author":"DJ Hellen","year":"2023","unstructured":"Hellen, D. J. & Karpen, S. J. LiverQuant: an improved method for quantitative analysis of liver pathology. Bio-Protoc. 13, e477 (2023).","journal-title":"Bio-Protoc."},{"key":"9484_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 1\u20137 (2017).","journal-title":"Sci. Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09484-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:03:46Z","timestamp":1770120226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09484-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9484"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09484-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: L.G.G. is an inventor on patents licensed to CN BioInnovations. J.J. and D.D. are employed\/shareholders of NovoNordisk A\/S. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}